77.72
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ALC Giù?
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$77.41
Aprire:
$77.81
Volume 24 ore:
493.52K
Relative Volume:
0.27
Capitalizzazione di mercato:
$38.27B
Reddito:
$10.03B
Utile/perdita netta:
$1.07B
Rapporto P/E:
35.82
EPS:
2.17
Flusso di cassa netto:
$1.39B
1 W Prestazione:
-1.58%
1M Prestazione:
-11.48%
6M Prestazione:
-12.72%
1 anno Prestazione:
-21.27%
Alcon Inc Stock (ALC) Company Profile
Nome
Alcon Inc
Settore
Industria
Telefono
-
Indirizzo
-
Confronta ALC con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
ALC
Alcon Inc
|
77.71 | 38.27B | 10.03B | 1.07B | 1.39B | 2.17 |
![]()
ISRG
Intuitive Surgical Inc
|
435.24 | 155.58B | 9.15B | 2.63B | 1.99B | 7.17 |
![]()
BDX
Becton Dickinson Co
|
187.57 | 53.24B | 21.39B | 1.61B | 2.55B | 5.56 |
![]()
RMD
Resmed Inc
|
271.17 | 39.71B | 5.15B | 1.40B | 1.65B | 9.51 |
![]()
WST
West Pharmaceutical Services Inc
|
257.60 | 18.52B | 2.96B | 487.70M | 344.00M | 6.68 |
Alcon Inc Stock (ALC) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-08-21 | Downgrade | JP Morgan | Overweight → Neutral |
2025-05-20 | Downgrade | Deutsche Bank | Buy → Hold |
2025-05-14 | Reiterato | BTIG Research | Buy |
2025-03-28 | Reiterato | Needham | Buy |
2025-03-25 | Aggiornamento | BofA Securities | Neutral → Buy |
2025-01-24 | Reiterato | Needham | Buy |
2025-01-10 | Aggiornamento | Redburn Atlantic | Neutral → Buy |
2024-12-17 | Reiterato | Needham | Buy |
2024-11-12 | Reiterato | Needham | Buy |
2024-10-10 | Aggiornamento | Redburn Atlantic | Sell → Neutral |
2024-09-10 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
2024-07-15 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
2024-05-15 | Aggiornamento | Oppenheimer | Perform → Outperform |
2024-04-10 | Iniziato | Goldman | Buy |
2024-03-14 | Iniziato | RBC Capital Mkts | Sector Perform |
2024-02-06 | Ripresa | KeyBanc Capital Markets | Overweight |
2024-01-23 | Iniziato | Bernstein | Outperform |
2023-12-18 | Downgrade | Redburn Atlantic | Neutral → Sell |
2023-12-12 | Iniziato | Stifel | Buy |
2023-12-04 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
2023-08-17 | Aggiornamento | JP Morgan | Neutral → Overweight |
2023-05-30 | Ripresa | Morgan Stanley | Equal-Weight |
2023-05-10 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
2023-03-01 | Aggiornamento | Societe Generale | Sell → Hold |
2022-12-22 | Iniziato | Mizuho | Buy |
2022-11-17 | Downgrade | Societe Generale | Hold → Sell |
2022-08-11 | Downgrade | Societe Generale | Buy → Hold |
2022-05-13 | Ripresa | Credit Suisse | Outperform |
2022-05-12 | Aggiornamento | Stephens | Equal-Weight → Overweight |
2022-04-08 | Iniziato | Needham | Buy |
2022-03-11 | Iniziato | BofA Securities | Buy |
2022-01-18 | Downgrade | Stephens | Overweight → Equal-Weight |
2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2021-10-01 | Iniziato | Oppenheimer | Perform |
2021-07-14 | Iniziato | Deutsche Bank | Buy |
2021-05-06 | Aggiornamento | Citigroup | Sell → Neutral |
2021-03-22 | Aggiornamento | BTIG Research | Neutral → Buy |
2020-11-12 | Downgrade | Guggenheim | Buy → Neutral |
2020-07-06 | Downgrade | Citigroup | Neutral → Sell |
2020-07-06 | Iniziato | KeyBanc Capital Markets | Sector Weight |
2020-06-16 | Aggiornamento | Guggenheim | Neutral → Buy |
2020-04-08 | Downgrade | Robert W. Baird | Outperform → Neutral |
2020-03-26 | Aggiornamento | Argus | Hold → Buy |
2020-03-24 | Aggiornamento | Societe Generale | Sell → Hold |
2020-03-13 | Aggiornamento | UBS | Neutral → Buy |
2020-03-05 | Iniziato | Citigroup | Neutral |
2020-02-26 | Aggiornamento | Berenberg | Hold → Buy |
2020-01-08 | Iniziato | Argus | Hold |
2019-10-29 | Iniziato | Stephens | Equal-Weight |
2019-08-21 | Reiterato | BofA/Merrill | Neutral |
2019-06-24 | Iniziato | SVB Leerink | Mkt Perform |
2019-06-14 | Iniziato | BTIG Research | Neutral |
2019-05-10 | Iniziato | Robert W. Baird | Outperform |
2019-05-02 | Iniziato | Credit Suisse | Outperform |
Mostra tutto
Alcon Inc Borsa (ALC) Ultime notizie
STAAR Surgical Announces Merger with Alcon - TipRanks
51% Premium: Medical Device Leader Alcon to Acquire STAAR Surgical in Premium Cash Deal Worth $28 Per Share - Stock Titan
38% Faster Teardown: Alcon's New UNITY VCS System Transforms Cataract and Retinal Surgery Efficiency - Stock Titan
Risk Check: Whats the MACD signal for Alcon IncShare Buyback & Consistent Income Trade Ideas - خودرو بانک
Swiss eye-care giant acquires Poulsbo medical device firm - The Business Journals
Aug Breakouts: How is Alcon Inc managing supply chain issuesWeekly Trend Report & Growth Focused Stock Reports - خودرو بانک
Alcon Sues Tesla, Musk Over AI-Generated Blade Runner 2049 Imagery - WebProNews
Aug Opening: Whats the beta of Alcon Inc stockJuly 2025 Update & High Accuracy Investment Signals - خودرو بانک
Alcon Acquires LumiThera to Boost Dry AMD Treatment Options - WebProNews
STAAR Surgical's largest holder to vote against Alcon bid - MSN
Alcon up 4% as FDA approves Tryptyr drops for dry eye - MSN
The past year for Alcon (VTX:ALC) investors has not been profitable - Yahoo Finance
Fuchs Endothelial Corneal Dystrophy Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | ProQR Therapeutics, Kowa Pharmaceuticals, Trefoil Therapeutics, Alcon Inc., Emmecell - Barchart.com
North America Vision Care Market Report 2025-2033 | EssilorLuxottica, Johnson & Johnson Vision, CooperVision, Bausch + Lomb, and Alcon Lead the 37.7 Bn Competitive Landscape - Yahoo Finance
Exclusive: Shareholder revolt threatens Alcon’s takeover of STAAR Surgical - Investing.com
New company OpZira formed following Alcon’s acquisition of LumiThera - Ophthalmology Times
Alcon AG stock hits 52-week low at 77.71 USD By Investing.com - Investing.com Nigeria
Alcon announces launch of wavelight plus, fully personalized LASIK treatment, in US and Canada - Ophthalmology Times
STAA Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of STAAR Surgical Company is Fair to Shareholders - GlobeNewswire Inc.
Hyperopia Market Overview: Epidemiology, Emerging Therapies, and Key Players | Featuring Nevakar, Zeimer Ophthalmic Systems AG, Carl Zeiss Meditec AG, AbbVie, Sydnexis, ALCON Inc., Bausch Health Compa - Barchart.com
Alcon AG stock hits 52-week low at 77.71 USD - Investing.com
Alcon launches first fully personalized LASIK treatment - Eyes On Eyecare
Alcon completes acquisition of LumiThera - Modern Retina
Swing Trade: Will Alcon Inc. benefit from rate cutsWeekly Gains Report & Real-Time Stock Price Movement Reports - Lancaster City Council
Does Alcon Inc. offer margin of safetyCPI Data & Technical Entry and Exit Alerts - Lancaster City Council
Alcon announces first fully personalized LASIK treatment with wavelight plus in the US and Canada - Eyes On Eyecare
North America Intraocular Lens Market Forecast and Company - GlobeNewswire
North America Intraocular Lens Market Forecast and Company Analysis Report 2025-2033 Featuring Alcon, Bausch, Hoya, Johnson & Johnson, STAAR Surgical, Carl Zeiss, Meditec, Novartis, and USIOL - Yahoo Finance
Eye Care’s Digital Revolution: Alcon’s ESCRS 2025 Launches Signal the Future of a $90B Market - MarketsandMarkets
Dana Lynn Alcon Obituary (2025)Price, UTMitchell Funeral Home, Inc.Price - Legacy.com
Short Term Trend Reversal in Alcon Inc. PossibleJuly 2025 Analyst Calls & Community Shared Stock Ideas - beatles.ru
Candlestick Reversal Detected on Alcon Inc.’s ChartTrade Signal Summary & High Conviction Buy Zone Picks - beatles.ru
Alcon Inc. Volume Confirms Breakout — Analysts Bullish2025 Bull vs Bear & Smart Swing Trading Alerts - beatles.ru
OpZira launches with LumiThera diagnostic product line - Eyes On Eyecare
Alcon Inc. Moves Into Bullish Territory Based on MACDJuly 2025 PreEarnings & Verified Momentum Watchlists - beatles.ru
Is Alcon Inc. Forming a Bottom PatternJuly 2025 Technicals & Free Accurate Trade Setup Notifications - beatles.ru
Alcon Launches Innovations and Highlights New Study Findings At ESCRS 2025 - MarketScreener
Alcon Inc. Recovery Potential Based on Technical ToolsAnalyst Downgrade & Real-Time Chart Pattern Alerts - beatles.ru
Alcon Launches Groundbreaking Innovations and Highlights New Study Findings at ESCRS 2025 - Yahoo Finance
Alcon downgraded at J.P. Morgan on Q2 results - MSN
Heatmap analysis for Alcon Inc. and competitorsQuarterly Earnings Summary & Verified Swing Trading Watchlist - Newser
Fundamentals Check: Is Alcon Inc. stock technically oversoldJuly 2025 Snapshot & Weekly High Return Opportunities - خودرو بانک
Is Alcon Inc. a play on infrastructure spending2025 Trading Volume Trends & AI Driven Price Forecasts - خودرو بانک
What is Alcon Inc.’s book value per shareJuly 2025 PostEarnings & Target Return Focused Picks - خودرو بانک
Alcon officially purchases LumiThera - Eyes On Eyecare
Forecasting Alcon Inc. price range with options dataShare Buyback & Verified Trade Idea Suggestions - Newser
With 64% ownership of the shares, Alcon Inc. (VTX:ALC) is heavily dominated by institutional owners - simplywall.st
Alcon Completes Acquisition of LumiThera, Expands Footprint Into Retina Clinic and Dry AMD Space - VisionMonday.com
Technical analysis overview for Alcon Inc. stock2025 Market WrapUp & Community Trade Idea Sharing - Newser
Can Alcon Inc. hit a new high this monthJuly 2025 Short Interest & High Conviction Trade Alerts - Newser
Will earnings trigger a reversal in Alcon Inc.Weekly Earnings Recap & Verified Short-Term Plans - Newser
Alcon Inc Azioni (ALC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):